CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease. (Q48605528)

http://europepmc.org/abstract/MED/25121572

13 February 2018

title

CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease. (English)

1 reference

http://europepmc.org/abstract/MED/25121572

13 February 2018

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25121572%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

C Liguori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25121572%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

G Sancesario

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25121572%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

G M Sancesario

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25121572%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

M G Marciani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25121572%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

M Pierantozzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25121572%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

13 August 2014

1 reference

http://europepmc.org/abstract/MED/25121572

13 February 2018

published in

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25121572%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25121572%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25121572%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

655-659

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25121572%20AND%20SRC:MED&resulttype=core&format=json

CSF biomarkers predict rate of cognitive decline in Alzheimer disease.

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

CSF biomarkers predict a more malignant outcome in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Understanding risk factors for Alzheimer's disease: interplay of neuroinflammation, connexin-based communication and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Increased levels of soluble LR11 in cerebrospinal fluid of patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Involvement of oxidative stress in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Mitochondria in neuroplasticity and neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Role of tau phosphorylation by glycogen synthase kinase-3beta in the regulation of organelle transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Multiple-motor based transport and its regulation by Tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Glycogen synthase kinase-3beta and the p25 activator of cyclin dependent kinase 5 increase pausing of mitochondria in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Tau filament formation in transgenic mice expressing P301L tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308577

21 January 2018

Identifiers

DOI

10.1136/JNNP-2014-308577

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25121572%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference